Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver–bone model - Summary - MDSpire
Advertisement
Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver–bone model
To investigate how MASLD-induced hepatic dysfunction affects bone formation and degradation, particularly focusing on the mechanisms of disrupted vitamin D metabolism.
Key Findings:
MASLD suppresses the expression of CYP2R1 and CYP27A1, leading to reduced production of 25(OH)D3, which may have significant implications for bone health.
Impaired vitamin D metabolism correlates with decreased bone mineralization and mechanical stiffness, suggesting a direct link between liver dysfunction and skeletal integrity.
The co-culture system effectively captures the interactions between liver and bone cells, providing a valuable platform for future research.
Interpretation:
The findings suggest that disrupted hepatic vitamin D metabolism due to MASLD may contribute to impaired bone health, highlighting the need for further investigation into therapeutic strategies that target this metabolic pathway.
Limitations:
The in vitro model may not fully replicate the complexity of in vivo conditions, potentially limiting the applicability of findings.
Long-term effects and systemic interactions beyond the co-culture system were not assessed, which may overlook critical factors influencing bone health.
Conclusion:
The study establishes a novel in vitro model to explore the relationship between MASLD and bone health, emphasizing the role of hepatic vitamin D metabolism in bone homeostasis.
by Mohammad Majd Hammour, Lisa Herzberger, Yuxuan Xin, Guanqiao Chen, Melike Tombaz, Sabrina Ehnert, Fabian Springer, Georg Damm, Massoud Vosough, Jan G. Hengstler, Ursula Müller-Vieira, Andreas K. Nüssler, Romina H. Aspera-Werz
